IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
IQVIA HOLDINGS INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026
$265.88−1.02 (-0.38%)
Close on Oct 19, 2026
- Market cap
- $45.15B
- P/E (TTM)
- 32.9
- Dividend yield
- –
Share price
+$61.33 (+29.98%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
IQVIA HOLDINGS INC. grew revenue 7.3% to $16.63B over the twelve months to Mar 31, 2026. Operating income rose 0.4% to $2.20B, moving the operating margin from 14.1% to 13.2%. Free cash flow was $2.12B, down 2.2% from a year earlier.
Revenue
$16.63B
+7.3% vs. a year earlier
Operating income
$2.20B
+0.4% vs. a year earlier
Free cash flow
$2.12B
-2.2% vs. a year earlier
EPS, diluted
$8.07
+9.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $45.15B
- P/E ratio
- 32.9
- Price to sales
- 2.71
- Price to book
- 7.26
- Dividend yield
- –
- Free cash flow yield
- 4.69%
Fundamentals
- Revenue
- $16.63B
- Net income
- $1.39B
- EPS, diluted
- $8.07
- Free cash flow
- $2.12B
- Book value per share
- $36.64
- Diluted shares
- 170M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$16.63B+7.3% YoY
Gross profit
$5.49B+23.2% YoY
Operating income
$2.20B+0.4% YoY
Net income
$1.39B+3.8% YoY
EPS, diluted
$8.07+9.9% YoY
Free cash flow
$2.12B-2.2% YoY
Reported periodTrailing twelve months